← Leaderboards
Nancy U Lin
University Of Tx Md Anderson Can Ctr
$1,025,163
Attributed
$1,439,744
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,905,193 · 5
By mechanism
P50$10,352,418 · 4
R21$552,775 · 1
Top collaborators
- Kornelia Polyak4 shared
- Geoffrey I Shapiro4 shared
- Vandana Abramson2 shared
- Ana M. Gonzalez-Angulo2 shared
- Funda Meric-Bernstam2 shared
- Leif W Ellisen1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Lauren Averett Byers$9,117,683
- John V. Heymach$11,138,593
- Eduardo Vilar Sanchez$16,310,319
- Michael Davies$11,575,720
- Scott Kopetz$13,199,822
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmCancer CenterClinical TrialsLeadInnovationDana-Farber Cancer InstituteMorbidity - Disease RatePre-ClinicalCollaborationsPathway InteractionsFutureGrowthResistanceTumorMetastatic Malignant Neoplasm To BrainCareerAwardErbb2 GeneBloodBiometryInsightCancer BiologyClinicEnsure
Grant awards (10)
Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer$2,607,297
P50 · FY2025 · CA
Project 2: Rational approaches to improve treatment outcomes of patients with breast cancer brain metastases$277,223
P50 · FY2025 · CA · contact PI
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer$2,302,230
P50 · FY2023 · CA
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer$2,210,645
P50 · FY2022 · CA
Developmental Research Program$157,204
P50 · FY2022 · CA · contact PI
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer$2,345,277
P50 · FY2021 · CA
Developmental Research Program$176,701
P50 · FY2021 · CA · contact PI
Project 3: Improving therapeutic approaches for breast cancer brain metastases$275,841
P50 · FY2019 · CA · contact PI
Akt Inhibitor MK-2206 for Breast Cancers with a PIK3CA Mutation and/or PTEN loss$262,015
R21 · FY2012 · CA
Akt Inhibitor MK-2206 for Breast Cancers with a PIK3CA Mutation and/or PTEN loss$290,760
R21 · FY2011 · CA